Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-12-03
2000-03-28
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 530324, 530325, 530326, 530327, 530328, A61K 3808, A61K 3810, A61K 3816, C07K 708
Patent
active
060432209
ABSTRACT:
The invention is directed to antimicrobial peptides related to naturally-occurring protegrin peptides, and methods of using the peptides in a variety of contexts, including the treatment or prevention of infections, and diseases related thereto.
REFERENCES:
patent: 5434074 (1995-07-01), Gibson et al.
patent: 5464823 (1995-11-01), Lehrer et al.
patent: 5693486 (1997-12-01), Lebrer et al.
patent: 5708154 (1998-01-01), Smith et al.
patent: 5804558 (1998-09-01), Lehrer et al.
patent: 5994306 (1999-11-01), Chang et al.
Dayhoff. Atlas of Protein Sequencing and Structure. vol. 5, p. 96, 1972.
Schulz et al. Principles of Protein Structure, New York, Springer-Verlag, pp. 14-16, 1979.
Harwig et al., 1995, "Determination of Disulphide Bridges in PG-2, an Anti-microbial Peptide from Porcine Leukocytes", Journal of Peptide Science, 3:207-215.
Hu et al., 1991, "Isolation and Characterization of Corticostatic Peptides from Guinea Pig Bone Marrow," Biochem. Biophys. Res. Commun. 180:558-565.
Kokryakov et al., 1993, "Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins", FEBS Letters 327(2):231-236.
Masuda et al., 1992, "A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)," Biochem. Biophys. Res. Commun. 189(2):845-850.
Matsuzaki et al., 1991, "Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes", Biochimica et Biophysica Acta., 1070:259-264.
Matsuzaki et al., 1993, "Role of Disulfide Linkages in Tachyplesin-Lipid Interactions", Biochemistry, 32(43):11704-11710.
Mirgorodskaya et al., 1993, "Primary Structure of three cationic peptides from porcine neutrophils", FEBS, 330(3):339-342.
Muta et al., 1990, "Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new tachyplesin, tachyplesin III, and a processing intermediate of its precursor," J. Biochem (Tokyo) 108(2):261-266.
Otaka et al., 1994, "Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12,Lys7]-polyphemusin II)," Biol. Pharm. Bull. 17(12):1669-1672.
Park et al., 1992, "Conformation of Tachyplesin I from Tachypleus tridentatus When Interacting with Lipid Matrices", Biochemistry, 31(48):12241-12247.
Sonis, Ch. XL-14 "Oral Complications", Complications of Cancer and Their Treatments, pp. 2381-2388 (Not Dated).
Sonis, Section 6 "Oral Complications of Cancer Therapy", Adverse Effects of Treatment-Oral Complications of Cancer Chemotherapy, pp. 2385-2394 (Not Dated).
Soto et al., 1995, "Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recgonized by sera from dogs with leishmaniasis", Immunology Letters, 4:209-214.
Storici and Zanetti, 1993, "A Novel cDNA Sequence Encoding a Pig Leukocyte Antimicrobial Peptide with a Cathelin-Like Pro-Sequence", Biochemical and Biophysical Research Communications, 196(3):1363-1368.
Tamamura et al., 1993, "Antimicrobial Activity and Conformation of Tachyplesin I and its Analogs", Chemical and Pharmaceutical Bulletin, 41(5):978-980.
Tamamura et al., 1993, "A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide T22 ([Tyr.sup.5,12,Lys.sup.7 ]-polyphemusin II), determined by nuclear magnetic resonance", Biochimica et Biophysica Acta., 1163:209-216.
Zhao et al., 1994, "Identification of a new member of the protegrin family by cDNA cloning", FEBS Letters, 346:285-288.
Zhao et al., 1995, "The structure of porcine protegrin genes", FEBS Letters, 368:197-202.
Zhao et al., 1995, "Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39", FEBS Letters, 376:130-134.
Chang Conway C.
Chen Jie
Lehrer Robert I.
Radel Peggy A.
IntraBiotics Pharmaceuticals, Inc.
Russel Jeffrey E.
LandOfFree
Threonine-containing protegrins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Threonine-containing protegrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Threonine-containing protegrins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326124